Clinicians are Turning to Rectal Administration of Medications and Fluids

In the face of the current healthcare crisis, knowledgeable clinicians are turning to the clinically proven rectal route for the administration of medications and fluids. The Macy Catheter is designed to make per rectum administration a viable alternative to injectable (parenteral) administration.

Medical drug shortages have been a challenge for healthcare facilities long before the recent COVID pandemic. However, due to the increasing numbers of critically ill individuals needing injectable or IV medications, the supply continues to be strained. While it’s important for healthcare providers to have access to essential medications, manufacturing companies are falling behind in their ability to satisfy the ever-growing demand.

Injectable medication shortages continue to arise both systemically and locally. The disruptions in manufacturing and demand spikes have multiplied the challenges of catching up to the need. Natural disasters including severe storms, hurricanes, and fires have exposed vulnerabilities in supply chains all over the world. To make matters worse, the current Covid-19 crisis is stressing the system in ways that are thus far unmatched. However, in the face of the compounding healthcare crisis that’s continuing to put at-risk patients in more peril, solutions are coming to light. For example, more and more knowledgeable clinicians are turning to the clinically proven rectal route. While rectal administration does not solve the supply issues alone, it helps healthcare workers bypass the need for injectable drugs. The Macy Catheter is designed to make per rectum administration a viable alternative to injectable administration.

With this device, Hospi Corporation is now helping acute care facilities facing injectable medication shortages. Thanks to the Macy Catheter, rectal medication administration has been transformed. The method is now discreet, dignified, painless, and reliable. It has been used for years for patients facing serious or terminal illness, and is now starting to be used in other settings. Fortunately, pharmacists and doctors know that oral/non-sterile forms of many IV medications can be delivered rectally, and some are prescribing a micro-enema suspension via the Macy Catheter.

Drugs that provide symptomatic relief of respiratory distress, such as morphine, midazolam, lorazepam, and hydromorphone are in high demand. For critically ill Covid patients, these drugs are necessary despite the shortages. The needs they present, in turn, may lead to shortages for many other patients benefiting from such medications.

The publication of an article in the December issue of the Journal of Hospice and Palliative Nursing entitled “Field Notes From the Frontline of a COVID-19 Outbreak, Dyspnea Management for Hospitalized Patients at End-of-Life,” describes the use of the Macy Catheter in a New Jersey hospital facing a Covid crisis. It reports their success in shifting all comfort care patients to receive oral forms of medications via the Macy Catheter. This way, they were able to safeguard their remaining supplies of injectable formulations.

The Macy Catheter® is an in-dwelling, balloon retained rectal catheter developed to allow rectal administration of medications and fluids. It is the first FDA cleared and CE marked device of its kind and is protected by several issued patents.

The LiquiPill® accessory included in some kit configurations helps to prepare suspensions from tablets for micro-enema administration via the rectal catheter.

Release ID: 88994494